GRI BIO, Inc. Quarterly Comprehensive Income (Loss), Net of Tax, Attributable to Parent in USD from Q3 2020 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Summary
GRI BIO, Inc. quarterly/annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent history and growth rate from Q3 2020 to Q1 2023.
  • GRI BIO, Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending March 31, 2023 was -$2.4M, a 9.21% increase year-over-year.
  • GRI BIO, Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the twelve months ending March 31, 2023 was -$6.78M, a 27.2% increase year-over-year.
  • GRI BIO, Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2022 was -$7.02M, a 24.5% increase from 2021.
  • GRI BIO, Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2021 was -$9.31M, a 93% decline from 2020.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Trailing 12 Months (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Quarterly (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$6.78M -$2.4M +$243K +9.21% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$7.02M -$1.58M +$1.52M +48.9% Oct 1, 2022 Dec 31, 2022 10-K 2023-02-24
Q3 2022 -$8.54M -$1.03M +$227K +18% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-03
Q2 2022 -$8.76M -$1.77M +$542K +23.4% Apr 1, 2022 Jun 30, 2022 10-Q 2022-07-28
Q1 2022 -$9.31M -$2.64M -$1K -0.04% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$9.31M -$3.1M Oct 1, 2021 Dec 31, 2021 10-K 2023-02-24
Q3 2021 -$1.26M -$213K -20.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$2.31M Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-28
Q1 2021 -$2.64M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q3 2020 -$1.05M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.